President Signs Executive Order to Lower Some Drug Costs

Follow Drugslib on

Medically reviewed by Drugs.com.

By Stephanie Brown HealthDay Reporter

MONDAY, May 12, 2025 -- ​Today, President Donald Trump signed an executive order to lower the costs of some medications.

The executive order instructs the U.S. Department of Health and Human Services to align Medicare payments for drugs given in a doctor's office with the lowest prices paid by other nations. Drug manufacturers will have 30 days to lower the cost of prescription drugs in the United States or face new limits over what the government will pay.

This approach, referred to as the "most favored nation" approach, would link the prices the federal government pays pharmaceutical companies for certain drugs to the prices paid by a group of other economically advanced countries, according to the Associated Press.

This proposal is expected to affect specific medications covered under Medicare that are administered in a health care setting, such as infusions for cancer treatment and other injectable drugs. This change has the potential to generate considerable cost savings for the government.

However, the pharmaceutical industry strongly opposes the order. In 2020, President Trump signed a similar executive order, but a court order later blocked the rule from going into effect. At the time, the pharmaceutical industry said the move would give foreign governments the "upper hand" in deciding the value of medicines in the United States, adding that lower prices not only hurt profits but also have a detrimental effect on innovation and the development of new drugs.

This plan will likely only cover medications administered under Medicare Part B, the insurance for doctor's office visits, the AP reported. Medicare beneficiaries will still be responsible for a portion of the costs for these medications received during their doctor's visits. In addition, this new order likely excludes coverage for many commonly filled prescription medications.

Associated Press Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-13 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords